{"entity":{"type":"insider","cik":"0001788368","url":"/insider/0001788368","json_url":"/insider/0001788368.json","name":"Roberts Christopher D.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":10,"first":"2020-09-04","last":"2021-05-05","span_basis":"filed_date"},"name_variants":[{"name":"Roberts Christopher D.","source":"filing","n_filings":10,"first_seen":"2020-09-04","last_seen":"2021-05-05"}],"transactions":[{"id":4255181,"accession":"0000899243-21-018358","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-018358","line_url":"/filing/0000899243-21-018358#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":26.6409,"price_display":"26.64","price_state":"stated","total_value":66602.25,"total_display":"66,602.25","total_whole":"66,602","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-03","filed_date":"2021-05-05","scope":"insider"},{"id":4653729,"accession":"0000899243-21-015309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-015309","line_url":"/filing/0000899243-21-015309#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":25.539,"price_display":"25.54","price_state":"stated","total_value":63847.5,"total_display":"63,847.50","total_whole":"63,848","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-07","scope":"insider"},{"id":4759741,"accession":"0000899243-21-009904","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-009904","line_url":"/filing/0000899243-21-009904","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":26.10473392,"price_display":"26.10","price_state":"stated","total_value":65261.8348,"total_display":"65,261.83","total_whole":"65,262","shares_owned_after":4084.0,"shares_owned_after_display":"4,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-04","scope":"insider","n_lines":2},{"id":4507823,"accession":"0000899243-21-004959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-004959","line_url":"/filing/0000899243-21-004959#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":25.35,"price_display":"25.35","price_state":"stated","total_value":63375.0,"total_display":"63,375.00","total_whole":"63,375","shares_owned_after":3200.0,"shares_owned_after_display":"3,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-03","filed_date":"2021-02-04","scope":"insider"},{"id":4603447,"accession":"0000899243-21-000743","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-000743","line_url":"/filing/0000899243-21-000743","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.40986936,"price_display":"31.41","price_state":"stated","total_value":78524.6734,"total_display":"78,524.67","total_whole":"78,525","shares_owned_after":3737.0,"shares_owned_after_display":"3,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-04","filed_date":"2021-01-06","scope":"insider","n_lines":2},{"id":2169921,"accession":"0000899243-20-032759","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-032759","line_url":"/filing/0000899243-20-032759#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":32.4221,"price_display":"32.42","price_state":"stated","total_value":81055.25,"total_display":"81,055.25","total_whole":"81,055","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-03","filed_date":"2020-12-04","scope":"insider"},{"id":2953890,"accession":"0000899243-20-030997","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030997","line_url":"/filing/0000899243-20-030997#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":34.9,"price_display":"34.90","price_state":"stated","total_value":174500.0,"total_display":"174,500.00","total_whole":"174,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-13","scope":"insider"},{"id":2732808,"accession":"0000899243-20-030419","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030419","line_url":"/filing/0000899243-20-030419#line-2","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.9492,"price_display":"31.95","price_state":"stated","total_value":79873.0,"total_display":"79,873.00","total_whole":"79,873","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-04","scope":"insider"},{"id":3319780,"accession":"0000899243-20-027717","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-027717","line_url":"/filing/0000899243-20-027717","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":31.27509664,"price_display":"31.28","price_state":"stated","total_value":78187.7416,"total_display":"78,187.74","total_whole":"78,188","shares_owned_after":227.0,"shares_owned_after_display":"227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-05","filed_date":"2020-10-07","scope":"insider","n_lines":2},{"id":2513250,"accession":"0000899243-20-024374","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-024374","line_url":"/filing/0000899243-20-024374","is_derivative":false,"issuer_cik":"0001701541","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001701541","owner_cik":"0001788368","owner_name":"Roberts Christopher D.","owner_display_name":"Roberts Christopher D.","owner_url":"/insider/0001788368","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":29.59496016,"price_display":"29.59","price_state":"stated","total_value":73987.4004,"total_display":"73,987.40","total_whole":"73,987","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001701541","name":"Black Diamond Therapeutics, Inc.","url":"/issuer/0001701541","role":"Officer (Chief Scientific Officer)","n_filings":10,"first_seen":"2020-09-04","last_seen":"2021-05-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001788368","retrieved_at":"2026-08-27T03:49:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}